Dokter Maarten Deman
ActiveDokter Maarten Deman has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €16k and a net result of €71k. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 18% of 16527 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Checked score
Score 2025
75
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100=
Solvency42▼-58
Growth78=
Track record94
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €1k at 30 days acceptable
Liquidity tight (current ratio 1.13 against 17.66 in 2024; short-term debt: 82.7% and cash: 75.7% of total assets), and 82.8% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Seven signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
17.2%
Return on assets
76%
Age of the figures
9 mo
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 18% of 16527 sector peers (2025).
NBB · sector comparisonPosition among 16527 sector peers
Solvency
better than 18%
← weakest
strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 09-07-2026, 22 days ahead of the deadline.
NBB · 4 filingsDeviation from the deadline
2025
22 d early
2024
21 d early
2023
29 d early
2022
25 d early
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
22-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€16k▼ 90.2%
2024 · €164k
2022: €9k
2023: €72k
2024: €164k
2022 → 2025
Total assets
€94k▼ 46.0%
2024 · €173k
2022: €26k
2023: €88k
2024: €173k
2022 → 2025
Net result
€71k▼ 22.4%
2024 · €92k
2022: €4k
2023: €63k
2024: €92k
2022 → 2025
Working capital
€10k▼ 93.6%
2024 · €156k
2022: €99
2023: €61k
2024: €156k
2022 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line2022202320242025Trend
Equity€9k-€72k▲ 677%€164k▲ 127%€16k▼ 90.2%
Operating result€5k-€80k▲ 1,384%€117k▲ 46.2%€91k▼ 22.4%
Net result€4k-€63k▲ 1,365%€92k▲ 45.5%€71k▼ 22.4%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 22% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €94k
Fixed assets
€6k▼ 23.1%
Current assets
€87k▼ 47.1%
Equity and liabilities €94k
Equity
€16k▼ 90.2%
Debt
€77k▲ 728%
The debt ratio rises from 5.4% to 82.8%. Equity is lower and debt is higher.
Key figures and ratios
EBITDA
€93k▼
2024 · €121k
Cash flow
€73k▼
2024 · €95k
Solvency
17.2%▼
2024 · 94.6%
Current ratio
1.13▼
2024 · 17.66
Quick ratio
1.13▼
2024 · 17.66
Debt / equity
4.81▲
2024 · 0.06
ROE
441.6%▲
2024 · 55.9%
ROA
76.0%▲
2024 · 52.9%
Interest coverage
492.17▲
2024 · 131.31
Debt
€77k▲
2024 · €9k
Debt ≤ 1 year
€77k▲
2024 · €9k
Income taxes
€20k▼
2024 · €25k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€173k€94k▼
Fixed assets21/28€8k€6k▼
Tangible fixed assets22/27€6k€4k▼
Furniture and vehicles24€6k€4k▼
Financial fixed assets28€2k€2k=
Current assets29/58€165k€87k▼
Amounts receivable within one year40/41€10k€14k▲
Other amounts receivable41€10k€14k▲
Cash at bank and in hand54/58€153k€71k▼
Deferred charges and accrued income490/1€2k€3k▲
Equity and liabilities
Total equity and liabilities10/49€173k€94k▼
Equity10/15€164k€16k▼
Contributions10/11€5k€5k=
Reserves13€159k€11k▼
Distributable reserves133€159k€11k▼
Profit (loss) carried forward14-€0
Amounts payable17/49€9k€77k▲
Amounts payable within one year42/48€9k€77k▲
Trade debts44€2k€10k▲
Suppliers440/4€2k€10k▲
Taxes, remuneration and social security45€6k€16k▲
Taxes450/3€6k€16k▲
Other amounts payable47/48€2k€52k▲
Accrued charges and deferred income492/3€0€75▲
Income statement
Code20242025
Non-recurring operating income76A-€113
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€4k€2k▼
Other operating charges640/8€519€862▲
Gross operating margin9900€121k€94k▼
Operating profit (loss)9901€117k€91k▼
Financial income75/76B€808€0▼
Recurring financial income75€808€0▼
Financial charges65/66B€919€189▼
Recurring financial charges65€919€189▼
Profit (loss) for the period before taxes9903€117k€91k▼
Income taxes67/77€25k€20k▼
Profit (loss) for the period9904€92k€71k▼
Profit (loss) for the period to be appropriated9905€92k€71k▼
Appropriation of the result
Profit (loss) to be appropriated9906€92k€71k▼
Transfer from equity791/2-€159k
Transfer to equity691/2€92k€11k▼
To other reserves6921€92k€11k▼
Profit to be distributed694/7-€219k
Return on contributions (dividend)694-€219k
The notes to these accounts (13 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
09-07
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
10-07
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial
Highest result since 2022net €92k ▲45.5%
Operating result €117k, net result €92k, both a record.
31-12
Financial
Liquidity quadruplescurrent ratio 17.66
Current ratio from 4.93 to 17.66; short-term debt falls from €16k to €9k.
31-12
Financial
Equity above €150kEq €164k ▲127%
3 profitable years in a row build equity to €164k.
02-07
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
31-12
Financial
Liquidity times 5current ratio 4.93
Current ratio from 1.01 to 4.93.
06-07
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Wevelgem · 1 establishment unit since 2022
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Artoisstraat 298560 WevelgemGround area
1,876 m²
Building footprint
957 m²
Volume, LiDAR
6,956 m³
2 parcels, Flanders · tallest building 13.7 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
Dokter Maarten Deman
since 20222.337.126.215
2 parcels
Flanders
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 34041C0350/00L005 | Flanders | 1,458 m² | 1 · 729 m² | 13.7 m · 3 fl. |
| 34041C0188/00N005 | Flanders | 418 m² | 1 · 228 m² | 10.8 m · 3 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
ASCLEPIA MED
BE 1025.704.229
Charleroi · Eq €16k
CENTRE DE SERVICES D'EXPERTISES MEDICALES
BE 0433.088.469
Etterbeek · Eq €16k
Dr. Machtelt D'Halleweyn
BE 1028.764.974
Gent · Eq €16k
DOCTEUR SOPHIE RAPPAZZO
BE 0797.613.677
Esneux · Eq €16k
WOYP
BE 1013.538.053
Maaseik · Eq €16k
Of 9,124 companies in sector 86210 we hold annual accounts for 6,337. 2,886 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded06-10-2022
Fiscal year end31-12
Activities, NACEBEL
86210General medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 4 filingsAddress and cadastre registers
Data from official sources, last processed on 21-09-2026. Scores and ratios are computed by Checked and are not a credit decision.